AI Science Tracker
EN

Supervised spectral analysis distinguishes colorectal precancerous lesions in a 100-person serum study

Yangzhou University; Yangzhou Polytechnic Institute · 28 Mar 2025 · medicine

Discovery

Supervised spectral analysis distinguishes colorectal precancerous lesions in a 100-person serum study

Source check: Source checked. Not independent scientific confirmation.

Finding: A serum spectroscopy study analyzed 30 healthy controls,30 people with colorectal precancerous lesions and 40 with colorectal cancer. Supervised class-discrimination optimization after principal-component analysis distinguished these groups in five-fold cross-validation; the reported precancer-versus-other-groups AUC was 0.96. These are internal classification results from 100 participants, without an independent screening cohort or demonstrated clinical benefit. Spectral differences do not establish a molecular disease mechanism.

Technology: Optimal Class Discrimination and Compactness Optimization; support vector machine; k-nearest neighbors

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
After PCA preprocessing, supervised Optimal Class Discrimination and Compactness Optimization learned separation of diagnostic classes from labeled spectra. SVM and nearest-neighbor classifiers provided comparison models; PCA alone is not the enabling AI contribution.
Test and result
Five-fold cross-validation of spectra from 100 participants across three diagnostic groups; source reports precancer-versus-other-groups AUC 0.96. Multiple measurements per sample were averaged before analysis.
Limitation / still unknown
No external patient cohort, prospective screening validation or treatment-benefit study. Methods report averaging five spatial spectra per sample and five-fold cross-validation, but do not explicitly establish patient-grouped fold assignment or fold-local PCA and component selection; reported internal spectral classification is not established patient-level screening performance. Biochemical interpretations remain associations.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1002/btm2.70019 · https://pmc.ncbi.nlm.nih.gov/articles/PMC12478330/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Exact primary article-front DOI/title/PMCID and date; full relevant model Methods, Results and limitations; fresh PubMed publication types and correction/retraction relationship metadata..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.